Disclosures for "Disease Impact and Burden in Patients with SCN2A-Related Developmental and Epileptic Encephalopathy ")
-
Kelley Dalby has received personal compensation for serving as an employee of Praxis Precision Medicines. Kelley Dalby has stock in Praxis Precision Medicines. Kelley Dalby has stock in RogCon.
-
Mr. Snyder has received personal compensation for serving as an employee of Praxis Precision Medicines. Mr. Snyder has received stock or an ownership interest from Praxis Precision Medicines.
-
Dr. G Matthews has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Praxis Precision Medicines. Dr. G Matthews has stock in Praxis Precision Medicines.
-
Ms. Brimble has received personal compensation for serving as an employee of Invitae. Ms. Brimble has stock in Invitae. Ms. Brimble has stock in Ciitizen.
-
Mr. Beek has received personal compensation for serving as an employee of invitae. Mr. Beek has stock in invitae.
-
Ms. Berk has received personal compensation for serving as an employee of Invitae. Ms. Berk has stock in Invitae.
-
Dr. Oldham has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
-
Steven Petrou has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Praxis Precision Medicines. Steven Petrou has stock in Praxis Precision Medicines. The institution of Steven Petrou has received research support from Praxis Precision Medicines. The institution of Steven Petrou has received research support from Medical Research Future Fund. Steven Petrou has received intellectual property interests from a discovery or technology relating to health care. Steven Petrou has received intellectual property interests from a discovery or technology relating to health care.